Piper Jaffray adds Amylin Pharmaceuticals (Nasdaq: AMLN) to the Alpha List. Price target $62.

Piper analyst, Thomas Wei ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE